Roche in MS
Our goal is to give people living with multiple sclerosis an effective treatment which is generally well tolerated and has a convenient dosing regimen every 6 months1
Roche is committed to working with partners to support the MS community. We will do our utmost to provide relevant and valuable solutions to help improve the MS journey.
That’s why we’re already working on various initiatives, including:
Date of preparation: August 2020